Thailand Drug Discovery Outsourcing Market Size & Outlook
The drug discovery outsourcing market in Thailand is expected to reach a projected revenue of US$ 233.0 million by 2033. A compound annual growth rate of 10% is expected of Thailand drug discovery outsourcing market from 2026 to 2033.
Thailand drug discovery outsourcing market highlights
The Thailand drug discovery outsourcing market generated a revenue of USD 110.1 million in 2025 and is expected to reach USD 233.0 million by 2033.
The Thailand market is expected to grow at a CAGR of 10% from 2026 to 2033.
In terms of segment, lead identification & candidate optimization was the largest revenue generating workflow in 2025.
Other Associated Workflow is the most lucrative workflow segment registering the fastest growth during the forecast period.
Drug discovery outsourcing market data book summary
Market revenue in 2025
USD 110.1 million
Market revenue in 2033
USD 233.0 million
Growth rate
10% (CAGR from 2026 to 2033)
Largest segment
Lead identification & candidate optimization
Fastest growing segment
Other Associated Workflow
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, Other Associated Workflow
Key market players worldwide
Albany Molecular Research, Evotec SE, Labcorp Holdings Inc, GenScript ProBio, Pharmaceutical Product Development, Charles River Laboratories International Inc, Wuxi AppTec Co Ltd, Merck & Co Inc, Thermo Fisher Scientific Inc, Dalton Pharma Services, Jubilant Biosys, Qiagen NV, Eurofins Scientific SE, Dr. Reddy’s Laboratories, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, TCG Lifesciences, Syngene, Oncodesign, DiscoveRX, Domainex
Other key industry trends
In terms of revenue, Thailand accounted for 1.4% of the global drug discovery outsourcing market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, Japan drug discovery outsourcing market is projected to lead the regional market in terms of revenue in 2033.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 497.7 million by 2033.
Thailand’s drug discovery market is being driven by significant R&D spending. The presence of major early-stage development CROs, such as Charles River Laboratories and Envigo, is also driving the market. The changing landscape of drug discovery in Thailand is also leading to an increase in the demand for drug discovery outsourcing in the country.
For instance, several large companies in Thailand have increased their overall investment in drug discovery, with over 605 companies boosting their outsourcing and collaborative efforts, according to The Association of the British Pharmaceutical Industry (2018).
In addition, the growing number of clinical trials in the country is fueling the market's growth. For instance, Thailand conducted 6,872 clinical trials between 1999 and 2019, according to WHO’s ICTRP. This contributes to 1.31% of total clinical trials conducted globally in the same period.
Thailand Drug Discovery Outsourcing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Drug Discovery Outsourcing Market Outlook will help companies and investors design strategic landscapes.
Lead Identification & Candidate Optimization was the largest segment with a revenue share of 34.79% in 2025.
Horizon Databook has segmented the Thailand drug discovery outsourcing market based on target identification & screening, target validation & functional informatics, lead identification & candidate optimization, preclinical development, other associated workflow covering the revenue growth of each sub-segment from 2021 to 2033.
Thailand’s drug discovery market is being driven by significant R&D spending. The presence of major early-stage development CROs, such as Charles River Laboratories and Envigo, is also driving the market. The changing landscape of drug discovery in Thailand is also leading to an increase in the demand for drug discovery outsourcing in the country.
For instance, several large companies in Thailand have increased their overall investment in drug discovery, with over 605 companies boosting their outsourcing and collaborative efforts, according to The Association of the British Pharmaceutical Industry (2018).
In addition, the growing number of clinical trials in the country is fueling the market's growth. For instance, Thailand conducted 6,872 clinical trials between 1999 and 2019, according to WHO’s ICTRP. This contributes to 1.31% of total clinical trials conducted globally in the same period.
Thailand Drug Discovery Outsourcing Market Workflow Outlook (Revenue, USD Million , 2021-2033)
Target Identification & Screening
Target Validation & Functional Informatics
Lead Identification & Candidate Optimization
Preclinical Development
Other Associated Workflow
Thailand Drug Discovery Outsourcing Market Molecule Outlook (Revenue, USD Million , 2021-2033)
Small Molecules
Large Molecules
Thailand Drug Discovery Outsourcing Market Service Outlook (Revenue, USD Million , 2021-2033)
Chemistry Services
Biology Services
Thailand Drug Discovery Outsourcing Market Therapeutics Area Outlook (Revenue, USD Million , 2021-2033)
Respiratory system
Pain and Anesthesia
Oncology
Ophthalmology
Hematology
Cardiovascular
Endocrine
Gastrointestinal
Immunomodulation
Anti-infective
Central Nervous System
Dermatology
Genitourinary System
Others
Thailand Drug Discovery Outsourcing Market End Use Outlook (Revenue, USD Million , 2021-2033)
Pharmaceutical & Biotechnology companies
Academic Institutes
Reasons to subscribe to Drug Discovery Outsourcing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Drug Discovery Outsourcing Market Outlook databook
Our clientele includes a mix of Drug Discovery Outsourcing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand Drug Discovery Outsourcing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Thailand Drug Discovery Outsourcing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Thailand Drug Discovery Outsourcing Market, 2021-2033 (US$M)